Literature DB >> 21633048

Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero.

P Gazzaniga, C Raimondi, A Gradilone, M Di Seri, F Longo, E Cortesi, L Frati.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21633048     DOI： 10.1093/annonc/mdr292

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  11 in total

1.  Circulating tumor cells: highlight on practical implications.

Authors:  Paola Gazzaniga; Cristina Raimondi; Angela Gradilone; Giuseppe Naso; Enrico Cortesi; Luigi Frati
Journal:  Mol Diagn Ther       Date:  2012-02-01       Impact factor: 4.074

2.  Circulating tumor cells: exploring intratumor heterogeneity of colorectal cancer.

Authors:  Cristina Raimondi; Chiara Nicolazzo; Angela Gradilone; Giuseppe Giannini; Elena De Falco; Isotta Chimenti; Elisa Varriale; Siegfried Hauch; Linda Plappert; Enrico Cortesi; Paola Gazzaniga
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

3.  Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff?

Authors:  P Gazzaniga; C Raimondi; A Gradilone; G Biondi Zoccai; C Nicolazzo; O Gandini; F Longo; S Tomao; G Lo Russo; P Seminara; B Vincenzi; I Chimenti; M Cristofanilli; L Frati; E Cortesi
Journal:  J Cancer Res Clin Oncol       Date:  2013-06-05       Impact factor: 4.553

4.  Impact of chronic exposure to bevacizumab on EpCAM-based detection of circulating tumor cells.

Authors:  Chiara Nicolazzo; Isabella Massimi; Lavinia V Lotti; Simone Vespa; Cristina Raimondi; Fabio Maria Pulcinelli; Angela Gradilone; Paola Gazzaniga
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

5.  Clinical Significance of Circulating Tumor Cells in Hormone Receptor-positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab.

Authors:  Mark Jesus M Magbanua; Oleksandr Savenkov; Erik J Asmus; Karla V Ballman; Janet H Scott; John W Park; Maura Dickler; Ann Partridge; Lisa A Carey; Eric P Winer; Hope S Rugo
Journal:  Clin Cancer Res       Date:  2020-06-25       Impact factor: 12.531

6.  Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.

Authors:  Emanuela Fina; Andrea Necchi; Stefano Bottelli; Carolina Reduzzi; Sara Pizzamiglio; Chiara Iacona; Maria Grazia Daidone; Paolo Verderio; Vera Cappelletti
Journal:  Dis Markers       Date:  2017-02-22       Impact factor: 3.434

7.  Circulating tumor cells as a response monitor in stage IV non-small cell lung cancer.

Authors:  Stephanie N Shishido; Anders Carlsson; Jorge Nieva; Kelly Bethel; James B Hicks; Lyudmila Bazhenova; Peter Kuhn
Journal:  J Transl Med       Date:  2019-08-28       Impact factor: 5.531

Review 8.  EpCAMlow Circulating Tumor Cells: Gold in the Waste.

Authors:  Chiara Nicolazzo; Angela Gradilone; Flavia Loreni; Cristina Raimondi; Paola Gazzaniga
Journal:  Dis Markers       Date:  2019-09-17       Impact factor: 3.434

Review 9.  Evolving Clinical Utility of Liquid Biopsy in Gastrointestinal Cancers.

Authors:  Richard A Jacobson; Emily Munding; Dana M Hayden; Mia Levy; Timothy M Kuzel; Sam G Pappas; Ashiq Masood
Journal:  Cancers (Basel)       Date:  2019-08-13       Impact factor: 6.639

10.  A novel circulating tumor cell subpopulation for treatment monitoring and molecular characterization in biliary tract cancer.

Authors:  Carolina Reduzzi; Marta Vismara; Marco Silvestri; Luigi Celio; Monica Niger; Giorgia Peverelli; Filippo De Braud; Maria G Daidone; Vera Cappelletti
Journal:  Int J Cancer       Date:  2019-12-19       Impact factor: 7.396
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.